Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001193125-26-268202

Director sold 572 shares at an average $247.65 ($141,656)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
JEFFS ROGER Director 2026-06-10 Sale 10b5-1 −286 $246.18 $70,407 58,653 D: show line 1 in the form
JEFFS ROGER Director 2026-06-11 Sale 10b5-1 −286 $249.12 $71,248 58,367 D: show line 2 in the form
Open-market sales · 572 sh · avg $247.65 · $141,656
Loading xslF345X06/ownership.xml…